about
Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapyClinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservationUse of monoclonal antibodies in renal transplantation.Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Immunotherapy with regulatory T cells in transplantation.Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.Synchronized turbo apoptosis induced by cold-shockEffect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).Treatment satisfaction in renal transplant patients taking tacrolimus once daily.Alternaria infectoria phaeohyphomycosis in a renal transplant patient.Use of the platelet function analyzer to minimize bleeding complications after renal biopsy.Single-dose rituximab as induction in renal transplantation.The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile.Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells.Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.Diagnostic approach in patients with asymptomatic haematuria: efficient or not?Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cellsLower urinary tract symptoms after renal transplantation: are there changes over time?Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma PatientsCimetidine improves the reliability of creatinine as a marker of glomerular filtrationFollowing anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipientsRapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cellsEx vivo expansion of human CD4+ CD25high regulatory T cells from transplant recipients permits functional analysis of small blood samplesAllogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivityScreening for microalbuminuriaTolerizing effects of co-stimulation blockade rest on functional dominance of CD4+CD25+ regulatory T cellsKIR gene and KIR ligand analysis to predict graft rejection after renal transplantationUrinary albumin-total protein ratio: a new diagnostic tool to differentiate glomerular from nonglomerular hematuria?What to do with a failed renal allograft: take it or leave it?Effect of administration of apoptotic blebs on disease development in lupus miceCurrent perspectives to overcome a positive crossmatch in living donor renal transplantationBoth early and late apoptotic blebs are taken up by DC and induce IL-6 productionEffect of mild diarrhea on tacrolimus exposureNephrotic syndrome induced by pamidronateTreatment of steroid-resistant acute renal allograft rejection with alemtuzumab
P50
Q30845152-B8A6BBDF-8321-4C97-8A61-A0B69B0E2E0EQ33336577-EF2B8AC4-047A-45AA-B6C4-19D4A08BE754Q33367565-45A72902-1FA5-406A-AE3B-59AEDDE2E829Q33396236-EE01326A-E0DB-4752-9296-D85601A769A8Q36290085-2DA7A59C-06DE-4083-8569-2904A7B3CE52Q37773304-496890FA-2FCC-4CC5-BD17-85F6DFCB48BEQ38009874-33E59A74-A8B7-489C-A825-F19B16A9DDB1Q39640328-BC0556EC-7992-4B2D-BE97-F7CAF2B7DC0EQ42253695-F62BC604-AE2D-4054-B64C-6A55A5B6C9BDQ43641844-C3942FA0-51FA-4287-99E0-F25B319E29BCQ44314574-5D87AD69-F613-4C2E-A8A1-73BD15883124Q44437968-D47DA62B-683C-4A5D-A1EF-0D4197E48C4DQ44516666-DF204370-E9D0-4085-8A97-E18A0048DCF1Q44741830-68E17910-2EC2-4026-92FC-15C47496BAE6Q44899008-413E5104-79B4-49BC-9DB0-45F85DB00FBDQ45091871-57A6C2F2-F871-4A7A-ACF5-AB2FDDCF8618Q50905754-FF0BE924-249C-40C3-B716-9133AF075C0CQ50983859-6ADBF152-6762-4299-9325-D740A2EB04ABQ51490028-598F1A78-0959-4775-8E79-D7D9FD675D69Q51941730-B079A090-5469-463E-89AA-D6823E9568D5Q51982170-8E685A2E-2E42-45C3-BF2B-6DEEE117FE52Q56901651-620B021C-7FB8-42F7-BD1D-E313DDA5229FQ57307271-A1A2C9F0-1735-4230-BD36-98CAC8ABEB3AQ58619940-48C54B0F-AD6A-49D3-BEC7-0CA15C2A8E92Q67804930-B6E5C9BA-DB78-4C25-8180-94101E43154AQ79364663-20185789-80EE-4DB3-B23A-F1626695A74EQ79919091-809A0D0E-CF83-4DA7-AF66-637CCB03487AQ79964147-78A85515-A96B-4207-B83B-89B753FCF513Q80309072-8C5F7FA4-F679-4D02-BBDC-FD46235956C6Q81220435-52CF28BA-6D49-48E1-A306-5372DC6EEDF8Q81308284-D00B4F36-EB8D-49A4-8F28-F058CA402379Q81567984-15993755-2390-4175-B215-057DCEB9C1AAQ83054410-2876F93E-A7E6-43E0-80CA-D9FADFEB2D98Q83522527-78709D94-7BB5-41B1-B112-A86C2BD5A54FQ83573553-D2434444-B4EE-41BE-93F0-01B4D5C2CE22Q83797727-94E2EADA-3F8E-44A6-A035-6CE66C94D4C9Q84660863-7325DBC3-3CBE-48FE-A8C9-A4F79866BAC2Q84942327-CEDAB043-BDDE-4F6E-BF64-694B376737DEQ85075610-CCF37AA6-B489-4600-9073-4D50CA28CDFCQ85492528-0F680AEE-1B0B-45A2-AF6C-18285FCB678E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luuk B Hilbrands
@ast
Luuk B Hilbrands
@en
Luuk B Hilbrands
@es
Luuk B Hilbrands
@nl
type
label
Luuk B Hilbrands
@ast
Luuk B Hilbrands
@en
Luuk B Hilbrands
@es
Luuk B Hilbrands
@nl
prefLabel
Luuk B Hilbrands
@ast
Luuk B Hilbrands
@en
Luuk B Hilbrands
@es
Luuk B Hilbrands
@nl
P106
P31
P496
0000-0002-4935-9765